Institutional investors hold a majority ownership of GRFS through the 59.88% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2016, these large investors purchased a net $7.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ALLIANCEBERNSTEIN LTD. Bought 37.1 Thousand shares of Grifols SA
DANSKE BANK A/S (INVT MGMT) Bought 16.0 Thousand shares of Grifols SA
EQIS CAPITAL MANAGEMENT, INC. Bought 15.7 Thousand shares of Grifols SA